The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.

Cerone, Maria Antonietta; Mills, Tara C; Sharpe, Rowena; McBride, David; MacDonald, Moira; MacMahon, Suzanne; Mugalaasi, Hood; Rehal, Pauline; Rettino, Alessandro; Roberts, Helen; Ross, Mark; White, Donald Edward; Peden, John; Rawlinson, Janette; Ho, Steffan N; Hollingsworth, Simon; Popat, Sanjay; Middleton, Gary; Johnson, Peter; Swanton, Charles; consortium, SMP2

doi:10.25418/crick.22060205.v1

s41416-022-02107-8 (1).pdf (380.41 kB)

The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.

journal contribution

posted on 2023-02-09, 13:43 authored by Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary Middleton, Peter Johnson, Charles Swanton, SMP2 consortium

Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.